Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Morari

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Journal of Neurochemistry|March 16, 2007
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's diseaseFlora Mela, Matteo Marti, Andrzej Dekundy, et al.
Neurobiology of Disease|April 17, 2008
Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismRiccardo Viaro, Rosario Sanchez-Pernaute, Matteo Marti, et al.
Journal of Neurochemistry|March 19, 2005
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamineMatteo Marti, Massimiliano Manzalini, Martina Fantin, et al.
Biomedicines|April 23, 2022
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out MiceChiara Domenicale, Daniela Mercatelli, Federica Albanese, et al.
Journal of Neurochemistry|February 4, 2003
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptorsMatteo Marti, Francesca Paganini, Sara Stocchi, et al.
Annals of Clinical and Translational Neurology|July 1, 2015
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaSimone Bido, Nicola Solari, Marzia Indrigo, et al.
Frontiers in Aging Neuroscience|June 26, 2020
Translation Imaging in Parkinson's Disease: Focus on NeuroinflammationSara Belloli, Michele Morari, Valentina Murtaj, et al.
Scientific Reports|March 23, 2025
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.
Neurobiology of Disease|September 3, 2018
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged miceSalvatore Novello, Ludovico Arcuri, Sandra Dovero, et al.
Pharmacology Research & Perspectives|June 1, 2019
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomesDaniela Mercatelli, Paolo Bolognesi, Martina Frassineti, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Journal of Neurochemistry|March 16, 2007
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's diseaseFlora Mela, Matteo Marti, Andrzej Dekundy, et al.
Neurobiology of Disease|April 17, 2008
Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismRiccardo Viaro, Rosario Sanchez-Pernaute, Matteo Marti, et al.
Journal of Neurochemistry|March 19, 2005
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamineMatteo Marti, Massimiliano Manzalini, Martina Fantin, et al.
Biomedicines|April 23, 2022
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out MiceChiara Domenicale, Daniela Mercatelli, Federica Albanese, et al.
Journal of Neurochemistry|February 4, 2003
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptorsMatteo Marti, Francesca Paganini, Sara Stocchi, et al.
Annals of Clinical and Translational Neurology|July 1, 2015
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaSimone Bido, Nicola Solari, Marzia Indrigo, et al.
Frontiers in Aging Neuroscience|June 26, 2020
Translation Imaging in Parkinson's Disease: Focus on NeuroinflammationSara Belloli, Michele Morari, Valentina Murtaj, et al.
Scientific Reports|March 23, 2025
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.
Neurobiology of Disease|September 3, 2018
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged miceSalvatore Novello, Ludovico Arcuri, Sandra Dovero, et al.
Pharmacology Research & Perspectives|June 1, 2019
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomesDaniela Mercatelli, Paolo Bolognesi, Martina Frassineti, et al.
Pageof 10